Business Description
Korea Pharma Co Ltd
ISIN : KR7032300006
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.52 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | 3.56 | |||||
Interest Coverage | 1.78 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.1 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.3 | |||||
3-Year EBITDA Growth Rate | 6 | |||||
3-Year EPS without NRI Growth Rate | -70.9 | |||||
3-Year Book Growth Rate | 13.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.56 | |||||
9-Day RSI | 42.05 | |||||
14-Day RSI | 45.1 | |||||
6-1 Month Momentum % | -17.34 | |||||
12-1 Month Momentum % | 2.27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.1 | |||||
Quick Ratio | 2.32 | |||||
Cash Ratio | 1.64 | |||||
Days Inventory | 155.82 | |||||
Days Sales Outstanding | 68.33 | |||||
Days Payable | 69.79 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.28 | |||||
Dividend Payout Ratio | 0.24 | |||||
Forward Dividend Yield % | 0.28 | |||||
5-Year Yield-on-Cost % | 0.28 | |||||
Shareholder Yield % | 8.62 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.02 | |||||
Operating Margin % | 6.77 | |||||
Net Margin % | 3.73 | |||||
FCF Margin % | 4.17 | |||||
ROE % | 4.57 | |||||
ROA % | 2.38 | |||||
ROIC % | 9.62 | |||||
ROC (Joel Greenblatt) % | 12.54 | |||||
ROCE % | 6.81 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 63.12 | |||||
PE Ratio without NRI | 81.61 | |||||
PS Ratio | 2.35 | |||||
PB Ratio | 2.68 | |||||
Price-to-Tangible-Book | 2.84 | |||||
Price-to-Free-Cash-Flow | 56.34 | |||||
Price-to-Operating-Cash-Flow | 36.5 | |||||
EV-to-EBIT | 32.62 | |||||
EV-to-EBITDA | 21.33 | |||||
EV-to-Revenue | 2.16 | |||||
EV-to-FCF | 53.53 | |||||
Price-to-Graham-Number | 3.21 | |||||
Price-to-Net-Current-Asset-Value | 5.35 | |||||
Earnings Yield (Greenblatt) % | 3.07 | |||||
FCF Yield % | 1.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Korea Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 80,403.075 | ||
EPS (TTM) (â‚©) | 274.556 | ||
Beta | 1.35 | ||
Volatility % | 37.1 | ||
14-Day RSI | 45.1 | ||
14-Day ATR (â‚©) | 879.008538 | ||
20-Day SMA (â‚©) | 17870.5 | ||
12-1 Month Momentum % | 2.27 | ||
52-Week Range (â‚©) | 14550 - 29450 | ||
Shares Outstanding (Mil) | 10.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Korea Pharma Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Korea Pharma Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Korea Pharma Co Ltd Frequently Asked Questions
What is Korea Pharma Co Ltd(XKRX:032300)'s stock price today?
When is next earnings date of Korea Pharma Co Ltd(XKRX:032300)?
Does Korea Pharma Co Ltd(XKRX:032300) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |